Does Mounjaro Stop Cravings — and How Does That Actually Work?

Step 1: What happens in your body after each dose

Tirzepatide is injected once a week and begins working almost immediately after absorption into the bloodstream. It binds to GIP receptors and GLP-1 receptors in the gut, pancreas and brain. That second address (the brain) is key to the craving question. GLP-1 receptors in the hypothalamus and reward circuits are involved in how strongly food is anticipated and how satisfying it feels; tirzepatide's activity there appears to dial down what researchers sometimes call 'food reward salience', meaning food simply stops commanding the same mental real estate.

GIP receptor activation adds another layer. Animal and early human data suggest GIP signalling in the brain's reward centres reduces the motivational pull of high-fat, high-sugar foods specifically. That is why many patients say they can walk past the biscuit tin without a second thought, rather than relying on willpower to resist it. The NHS medicines page for tirzepatide describes both pathways and their role in appetite reduction in accessible terms.

Gastric emptying also slows, so food stays in the stomach longer. Fullness signals reach the brain earlier in a meal and persist afterwards. Taken together, the combined effect on physical hunger and cognitive craving is stronger than anything a single-receptor medicine can produce, which is part of why the SURMOUNT-1 trial, involving 2,539 adults, showed average weight losses of around 20–21% at the 15 mg dose over 72 weeks.

Step 2: When people typically notice the craving effect, and why the dose matters

Treatment starts at 2.5 mg, a dose chosen to let the body adjust rather than deliver the full therapeutic effect straight away. At this level some people notice appetite change quickly; others feel little difference and wonder whether it is working. That is normal. The craving-reduction effect generally becomes more pronounced as the prescriber titrates the dose upward (typically in four-week steps) towards the maintenance level that suits each person.

Timing within the weekly cycle also matters. Tirzepatide's blood levels peak in the day or two after injection, then gradually taper. Some people find cravings creep back slightly in the final day before the next dose is due. If that pattern is consistent, it is worth mentioning at your next clinical review rather than adjusting anything yourself, the prescriber can consider whether timing or titration needs revisiting. You can explore how tirzepatide affects cravings across the dosing cycle in more detail on a dedicated page.

People transferring from a different medicine sometimes ask whether the craving effect starts immediately or needs to build. It varies. A prescriber who has reviewed your history is better placed to set expectations than any general guide can be.

Step 3: Sugar cravings and chocolate cravings, is the effect selective?

One of the more surprising things patients report is that the reduction in cravings seems disproportionately strong for sweet and ultra-processed foods. Research into GIP and GLP-1 receptor activity in reward circuits offers a plausible explanation: those pathways appear particularly involved in the anticipatory pleasure attached to high-sugar, high-fat combinations. So while overall appetite falls, the pull towards cake or crisps often falls further and faster than general hunger does.

This is not universal. Some people find sugar cravings on Mounjaro persist or shift to different foods, and others notice that chocolate cravings specifically linger even when other food thoughts have quietened. Both experiences are real and worth tracking. A food diary in the first few weeks can help you notice patterns to raise with your prescriber or aftercare team.

It is also worth knowing that some complementary supplements are marketed alongside GLP-1 medicines, if you are considering anything alongside treatment, discuss it first. Our clinical team regularly field questions about combining supplements such as lion's mane with Mounjaro, and the answer almost always starts with your prescriber.

Step 4: When cravings come back, and what that means

Not everyone finds that reduced cravings persist throughout treatment. Some people notice the effect fades after months, particularly if they have been at the same dose for a long time. Others report that cravings return more strongly during stressful periods, illness, or after a missed dose. There is a dedicated look at what to do when Mounjaro cravings come back if that is the pattern you are experiencing.

It is important not to confuse a temporary return of appetite with treatment failure. Physiological stress, poor sleep and alcohol can all temporarily override the medicine's appetite signals. The practical question (whether the current dose is still appropriate, whether lifestyle factors are in play, or whether a review is needed) is one for a clinician.

If you are thinking about the cost of staying on treatment over time, the Mounjaro pricing page sets out how private treatment is priced in the UK, including what a transparent price should cover. For a broader look at the treatment itself, the Mounjaro overview covers licensing, eligibility and how the process works at nume. The NICE appraisal of tirzepatide (TA1026) is the authoritative UK clinical recommendation and worth reading if you want the full policy picture.